Next Article in Journal
Booster COVID-19 Vaccines for Immune-Mediated Inflammatory Disease Patients: A Systematic Review and Meta-Analysis of Efficacy and Safety
Next Article in Special Issue
Factors Involved in Removing the Non-Structural Protein of Foot-and-Mouth Disease Virus by Chloroform and Scale-Up Production of High-Purity Vaccine Antigens
Previous Article in Journal
Immunological Cross-Protection between Different Rabbit Hemorrhagic Disease Viruses—Implications for Rabbit Biocontrol and Vaccine Development
Previous Article in Special Issue
Validation of Pretreatment Methods for the In-Process Quantification of Foot-and-Mouth Disease Vaccine Antigens
 
 
Article

Article Versions Notes

Vaccines 2022, 10(5), 667; https://doi.org/10.3390/vaccines10050667
Action Date Notes Link
article pdf uploaded. 22 April 2022 15:44 CEST Version of Record https://www.mdpi.com/2076-393X/10/5/667/pdf-vor
article xml file uploaded 24 April 2022 11:06 CEST Original file -
article xml uploaded. 24 April 2022 11:06 CEST Update https://www.mdpi.com/2076-393X/10/5/667/xml
article pdf uploaded. 24 April 2022 11:06 CEST Updated version of record https://www.mdpi.com/2076-393X/10/5/667/pdf
article html file updated 24 April 2022 11:08 CEST Original file -
article html file updated 25 April 2022 10:03 CEST Update -
article html file updated 2 August 2022 20:22 CEST Update https://www.mdpi.com/2076-393X/10/5/667/html
Back to TopTop